Perioperative stromal depletion by PEGPH20 in pancreatic ductal adenocarcinoma.

被引：0
|
作者：
Ko, Andrew H.
Cinar, Pelin
Tempero, Margaret A.
Nakakura, Eric K.
Yeh, Benjamin M.
Chondros, Dimitrios
机构：
[1] UCSF Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA
[2] Stanford Univ, Med Ctr, Stanford, CA 94305 USA
[3] Univ Calif San Francisco, San Francisco, CA 94143 USA
[4] Univ Calif San Francisco, Pancreas Ctr, San Francisco, CA 94143 USA
[5] Halozyme Therapeut, San Diego, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 04期
关键词：
D O I：
10.1200/jco.2016.34.4_suppl.tps476
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS476
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Evaluation of putative prognostic tissue biomarkers in pancreatic ductal adenocarcinoma.
    Winter, J. M.
    Tang, L. H.
    Klimstra, D. S.
    Brennan, M. F.
    O'Reilly, E. M.
    Jarnagin, W. R.
    Allen, P. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [42] The tumor immune microenvironment is decisive in the survival of pancreatic ductal adenocarcinoma.
    Aziz, Hosein M.
    Saida, Lawlaw
    de Koning, Willem
    Stubbs, Andrew
    Li, Yunlei
    van Eijck, Casper H. J.
    Mustafa, Dana A. M.
    CANCER RESEARCH, 2021, 81 (22) : 80 - 81
  • [43] Oncogenic roles of CEACAM6 in pancreatic ductal adenocarcinoma.
    Mahadevan, Daruka
    Pandey, Ritu
    Chen, Yuliang
    Essif, Jacob
    Al-Khinji, Aisha
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [44] Non-Invasive Monitoring of Stromal Biophysics with Targeted Depletion of Hyaluronan in Pancreatic Ductal Adenocarcinoma
    Maloney, Ezekiel
    DuFort, Christopher C.
    Provenzano, Paolo P.
    Farr, Navid
    Carlson, Markus A.
    Vohra, Ravneet
    Park, Joshua
    Hingorani, Sunil R.
    Lee, Donghoon
    CANCERS, 2019, 11 (06):
  • [45] NAMPT expression in stage I/II pancreatic ductal adenocarcinoma.
    Davis, Katelynn
    Dunseth, Craig
    Mott, Sarah L.
    Bellizzi, Andrew
    Chan, Carlos Hou Fai
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [46] The role of p53 in the development of pancreatic ductal adenocarcinoma.
    Hanson, Kathryn J.
    Flowers, Brittany M.
    Hughes, Nicholas
    Vogel, Hannes
    Cong, Le
    Attardi, Laura D.
    CANCER RESEARCH, 2021, 81 (22) : 58 - 58
  • [47] The role of whole genome duplication in progression of pancreatic ductal adenocarcinoma.
    Hummel, Lauren
    Xie, Irene
    Ng, Karen
    Zhang, Amy
    Ramotar, Stephanie
    Dodd, Anna
    O'Kane, Grainne
    Knox, Jennifer
    Wilson, Julie
    Gallinger, Steven
    Notta, Faiyaz
    CANCER RESEARCH, 2022, 82 (22) : 81 - 81
  • [48] Prognostic influence of waiting time in management of pancreatic ductal adenocarcinoma.
    Suzuki, Rei
    Takagi, Tadayuki
    Hikichi, Takuto
    Ohira, Hiromasa
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [49] Cell-density dependent migration in pancreatic ductal adenocarcinoma.
    Karl, M.
    Jayatilaka, H.
    Wirtz, D.
    MOLECULAR BIOLOGY OF THE CELL, 2017, 28
  • [50] Efficacy and tolerability of tremelimumab in patients with metastatic pancreatic ductal adenocarcinoma.
    Sharma, Padmanee
    Dirix, Luc
    De Vos, Filip Yves Francine Leon
    Allison, James Patrick
    Decoster, Lore
    Zaucha, Renata
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
12345